AbClon Inc (174900) - Total Liabilities

Latest as of September 2025: ₩9.44 Billion KRW ≈ $6.40 Million USD

Based on the latest financial reports, AbClon Inc (174900) has total liabilities worth ₩9.44 Billion KRW (≈ $6.40 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

AbClon Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how AbClon Inc's total liabilities have evolved over time, based on quarterly financial data. See AbClon Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

AbClon Inc Competitors by Total Liabilities

The table below lists competitors of AbClon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Panin Financial Tbk JK:PNLF	Indonesia	Rp174.93 Trillion
Canopy Growth Corp NASDAQ:CGC	USA	$348.02 Million
Lux Industries Limited NSE:LUXIND	India	Rs12.03 Billion
Chang Lan Electric Technology Co Ltd SHE:002879	China	CN¥599.45 Million
Orion Engineered Carbons SA NYSE:OEC	USA	$1.55 Billion
Aurora Corp TW:2373	Taiwan	NT$9.26 Billion
Shenzhen Sunyes Electronic Manufacturing Holding Co Ltd SHE:002388	China	CN¥1.64 Billion
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	USA	$5.30 Million

Liability Composition Analysis (2015–2024)

This chart breaks down AbClon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AbClon Inc (174900) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbClon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbClon Inc (2015–2024)

The table below shows the annual total liabilities of AbClon Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩18.78 Billion ≈ $12.72 Million	+3.24%
2023-12-31	₩18.19 Billion ≈ $12.33 Million	+4.18%
2022-12-31	₩17.46 Billion ≈ $11.83 Million	+66.76%
2021-12-31	₩10.47 Billion ≈ $7.09 Million	-3.07%
2020-12-31	₩10.80 Billion ≈ $7.32 Million	-6.81%
2019-12-31	₩11.59 Billion ≈ $7.85 Million	+15.84%
2018-12-31	₩10.00 Billion ≈ $6.78 Million	+188.10%
2017-12-31	₩3.47 Billion ≈ $2.35 Million	-13.84%
2016-12-31	₩4.03 Billion ≈ $2.73 Million	+40.95%
2015-12-31	₩2.86 Billion ≈ $1.94 Million	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$408.87 Million

₩603.34 Billion KRW

Market Cap Rank

#13425 Global

#413 in Korea

Share Price

₩31600.00

Change (1 day)

-7.06%

52-Week Range

₩9890.00 - ₩89100.00

All Time High

₩90600.00